Mitin N, Rossman KL, Der CJ. Signaling interplay in Ras superfamily function. Curr Biol. 2005;15(14):R563–74.

Article  CAS  PubMed  Google Scholar 

DeFeo D, et al. Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus. Proc Natl Acad Sci U S A. 1981;78(6):3328–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cox AD, et al. Drugging the undruggable RAS: mission possible? Nat Rev Drug Discov. 2014;13(11):828–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hobbs GA, Der CJ, Rossman KL. RAS isoforms and mutations in cancer at a glance. J Cell Sci. 2016;129(7):1287–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quinlan MP, Settleman J. Isoform-specific ras functions in development and cancer. Future Oncol. 2009;5(1):105–16.

Article  CAS  PubMed  Google Scholar 

Bos JL. The ras gene family and human carcinogenesis. Mutat Res. 1988;195(3):255–71.

Article  CAS  PubMed  Google Scholar 

Qunaj L, May MS, Neugut AI, Herzberg BO. Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer. Front Oncol. 2023;13:1252516. https://doi.org/10.3389/fonc.2023.1252516.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo TA, et al. Clinicopathologic features and prognostic value of KRAS, NRAS and BRAF mutations and DNA mismatch repair status: A single-center retrospective study of 1,834 Chinese patients with Stage I–IV colorectal cancer. Int J Cancer. 2019;145(6):1625–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fernandez-Medarde A, Santos E. Ras in cancer and developmental diseases. Genes Cancer. 2011;2(3):344–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Modest DP, et al. Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group. Ann Oncol. 2016;27(9):1746–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ottaiano A, et al. Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer. Cell Death Dis. 2020;11(4):275.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rajagopalan H, et al. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature. 2002;418(6901):934.

Article  CAS  PubMed  Google Scholar 

De Roock W, et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. Lancet Oncol. 2010;11(8):753–62.

Article  CAS  PubMed  Google Scholar 

Li S, et al. Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts. Br J Cancer. 2014;110(11):2812–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diehl AC, et al. KRAS mutation variants and co-occurring PI3K pathway alterations impact survival for patients with pancreatic ductal Adenocarcinomas. Oncologist. 2022;27(12):1025–33.

Article  PubMed  PubMed Central  Google Scholar 

Schutte M, et al. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res. 1997;57(15):3126–30.

CAS  PubMed  Google Scholar 

Lee JK, et al. Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors. Npj Precis Oncol. 2022;6(1):91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shackelford RE, et al. KRAS testing: a tool for the implementation of personalized medicine. Genes Cancer. 2012;3(7):459–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Timar J, Kashofer K. Molecular epidemiology and diagnostics of KRAS mutations in human cancer. Cancer Metastasis Rev. 2020;39(4):1029–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tanaka J, et al. KRAS genotyping by digital PCR combined with melting curve analysis. Sci Rep. 2019;9(1):2626.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, et al. Utility of next-generation sequencing technologies for the efficient genetic resolution of haematological disorders. Clin Genet. 2016;89(2):163–72.

Article  CAS  PubMed  Google Scholar 

Tsuchihara K, Yamashita R, Yoshino T, Shitara K, Watanabe J, Yasui H, Uetake H. Clonal and subclonal mutational landscapes in circulating tumor DNA in metastatic colorectal cancer: An exploratory analysis from the phase III PARADIGM study. In: Cancer Research. Vol. 80. USA: Amer Assoc Cancer Research; 2020. pp. 19106–14404.

Google Scholar 

Holm M, et al. Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing. PLoS ONE. 2020;15(e0239819):11.

Google Scholar 

Cook JH, Melloni GEM, Gulhan DC, et al. The origins and genetic interactions of KRAS mutations are allele- and tissue-specific. Nat Commun. 2021;12:1808. https://doi.org/10.1038/s41467-021-22125-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

https://hgvs-nomenclature.org/stable/recommendations/general/access. Accessed 1 May 2024.

de Macedo MP, de Lima LGCA, de Souza Begnami MDF, de Melo FM, Andrade LDB, Lisboa BCG, da Cunha IW. KRAS insertions in colorectal cancer: what do we know about unusual KRAS mutations? Exp Mol Pathol. 2014;96(2):257–60.

Article  PubMed  Google Scholar 

Favazza LA, Parseghian CM, Kaya C, Nikiforova MN, Roy S, Wald AI, Landau MS, Proksell SS, Dueker JM, Johnston ER, Brand RE, Bahary N, Gorantla VC, Rhee JC, Pingpank JF, Choudry HA, Lee K, Paniccia A, Ongchin MC, Zureikat AH, Singhi AD. KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy. Mod Pathol. 2020;33(9):1832–43. https://doi.org/10.1038/s41379-020-0560-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang D, et al. 161P Real-world large-scale study of KRAS fusions in Chinese non-small cell lung cancer patients: A multicenter study (Yangtze River Delta Lung Cancer Cooperation Group-002). J Thorac Oncol. 2021;16:786–784.

Article  Google Scholar 

Tew BY, Durand JK, Bryant KL, Hayes TK, Peng S, Tran NL, Gooden GC, Buckley DN, Der CJ, Baldwin AS, Salhia B. Genome-wide DNA methylation analysis of KRAS mutant cell lines. Sci Rep. 2020;10(1):10149. https://doi.org/10.1038/s41598-020-66797-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nuevo-Tapioles C, Philips MR. The role of KRAS splice variants in cancer biology. Front Cell Dev Biol. 2022;10:1033348. https://doi.org/10.3389/fcell.2022.1033348.

Article  PubMed  PubMed Central  Google Scholar 

Coley AB, Ward A, Keeton AB, Chen X, Maxuitenko Y, Prakash A, Li F, Foote JB, Buchsbaum DJ, Piazza GA. Pan-RAS inhibitors: Hitting multiple RAS isozymes with one stone. Adv Cancer Res. 2022;153:131–68. https://doi.org/10.1016/bs.acr.2021.07.009.

Article